本页面由Tiger Trade Technology Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

1.95
+0.05002.63%
盘后:1.950.00000.00%19:34 EDT
成交量:2.44万
成交额:4.75万
市值:591.14万
市盈率:0.00
高:2.02
开:1.91
低:1.91
收:1.90
52周最高:12.30
52周最低:1.90
股本:303.15万
流通股本:214.25万
量比:0.61
换手率:1.14%
股息:- -
股息率:- -
每股收益(TTM):-977.1003
每股收益(LYR):-1,791.0249
净资产收益率:-211.37%
总资产收益率:-77.12%
市净率:1.22
市盈率(LYR):0.00

数据加载中...

2022/03/24

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/13

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/26

招股说明书

Can-Fite BioPharma Ltd.
2021/08/26

招股说明书

F-1 - Registration statement for certain foreign private issuers
2021/03/25

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/30

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/07

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/27

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/22

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/10

招股说明书

F-1 - Registration statement for certain foreign private issuers
2020/06/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/01

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]